$RXMD It's pretty simple, really. Management has taken a careful and calculated approach to mostly organic growth that was "recently" funded by "relatively" high-quality convertible debt. It's been a slow burn for a couple years to pay off that debt, and you can see from all financial reports, the company has done a phenomenal job of maintaining value for shareholders with very limited dilution. However... most shareholders (in the OTC, of course) have been frustrated with this process because the stock has performed WELL below their expectations over that entire time. But it's simply due to the slow burn of constant - but very limited - dilution, and the resultant price-trade action that occurs during the process.
So the stock has been very much undervalued. But NOW - the good news is, if you were lucky enough to just stumble onto RXMD at this time... the timing couldn't be better. The debt is nearly paid off and is expected to be announced as such in the very near future; latest AUDITED financials are due next week and should confirm what a steal this company/stock is at today's price range; a plan is in place and the company will continue the process for uplisting to a large national exchange following next week's report... and other huge catalysts are in play that would take too much to lay out in this message.
NOW... looks what's been happening in the larger market. Tech investing... then rotation into "Value" recovery stocks, back and forth. Progressive Care / PharmcoRX (RXMD) represents the best of both, as well as a top-notch combination of the two.
Value AND Tech, and the Tech is in a sector with enormous growth potential... AND the company itself is situated with huge growth potential within that "enormous growth potential sector" AND has directed its tech and expertise in areas with incredibly high margins. So just try to imagine what exponential business growth in a sector that is growing exponentially looks like. Think double-digit compounding of double-digit gains in the value of the stock over the next several years. And RXMD is absolutely STACKED with catalysts for upward movement!
Just do some DD on this. Review the press releases and scan the financials. You'll quickly understand what the above comments really mean.
The recent bump up in the share price did not come from any news or event. Nothing from the company. It just moved. And it held well. Think about that, and about what is coming when the cheap dilution shares are confirmed DONE, as well as the other huge milestones upcoming.
AI
